Genentech, a member of the Roche Group, has announced plans to invest more than $700m in a new 700,000 square foot state-of-the-art drug manufacturing facility in Holly Springs, NC. The project will add more than 400 high-wage manufacturing jobs when the site is operational and more than 1,500 construction jobs during site development. The new…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
